Vyne Therapeutics Inc
NASDAQ:VYNE
Vyne Therapeutics Inc
NASDAQ:VYNE
Price:
0.5913
USD
0.66%
Market Closed
Market Cap:
$19.7m
Income Statement
Earnings Waterfall
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Income Statement
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Currency: USD
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
4
|
7
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
2
N/A
|
2
+44%
|
5
+103%
|
5
+1%
|
14
+209%
|
13
-6%
|
11
-21%
|
10
-2%
|
0
-97%
|
0
N/A
|
0
N/A
|
2
N/A
|
13
+668%
|
17
+24%
|
21
+26%
|
19
-7%
|
8
-58%
|
9
+10%
|
1
-90%
|
1
-4%
|
1
-19%
|
(3)
N/A
|
0
N/A
|
0
-15%
|
0
+2%
|
0
-14%
|
0
+18%
|
0
N/A
|
0
+14%
|
0
+2%
|
1
+2%
|
1
+21%
|
0
-21%
|
1
+10%
|
1
+9%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
13
+775%
|
16
+22%
|
20
+24%
|
0
N/A
|
0
N/A
|
7
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(22)
|
(27)
|
(34)
|
(42)
|
(55)
|
(59)
|
(65)
|
(68)
|
(68)
|
(77)
|
(76)
|
(106)
|
(265)
|
(268)
|
(272)
|
(242)
|
(73)
|
(66)
|
(40)
|
(39)
|
(37)
|
(25)
|
(35)
|
(32)
|
(34)
|
(31)
|
(30)
|
(31)
|
(32)
|
(38)
|
(44)
|
(46)
|
(43)
|
(38)
|
(30)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(5)
|
(7)
|
(9)
|
(11)
|
(12)
|
(15)
|
(19)
|
(26)
|
(22)
|
(53)
|
(73)
|
(82)
|
(90)
|
(70)
|
(48)
|
(42)
|
(20)
|
(19)
|
(19)
|
(9)
|
(16)
|
(15)
|
(14)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(12)
|
(12)
|
(11)
|
|
| Research & Development |
(17)
|
(23)
|
(29)
|
(35)
|
(46)
|
(48)
|
(53)
|
(53)
|
(49)
|
(51)
|
(54)
|
(53)
|
(53)
|
(47)
|
(44)
|
(32)
|
(24)
|
(24)
|
(20)
|
(20)
|
(19)
|
(17)
|
(18)
|
(17)
|
(20)
|
(18)
|
(16)
|
(17)
|
(17)
|
(24)
|
(31)
|
(33)
|
(31)
|
(26)
|
(19)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(139)
|
(139)
|
(139)
|
(140)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(20)
N/A
|
(25)
-24%
|
(30)
-18%
|
(37)
-26%
|
(40)
-8%
|
(46)
-13%
|
(55)
-20%
|
(57)
-5%
|
(67)
-18%
|
(77)
-14%
|
(76)
+1%
|
(104)
-37%
|
(252)
-142%
|
(252)
0%
|
(253)
0%
|
(222)
+12%
|
(65)
+71%
|
(59)
+9%
|
(39)
+34%
|
(38)
+3%
|
(37)
+3%
|
(28)
+23%
|
(34)
-22%
|
(31)
+8%
|
(34)
-6%
|
(30)
+9%
|
(29)
+4%
|
(31)
-5%
|
(30)
+1%
|
(37)
-22%
|
(44)
-17%
|
(45)
-4%
|
(43)
+5%
|
(38)
+12%
|
(30)
+21%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
0
|
(0)
|
(2)
|
(4)
|
(4)
|
(5)
|
(7)
|
(6)
|
(5)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
4
|
3
|
4
|
4
|
3
|
|
| Pre-Tax Income |
(20)
N/A
|
(25)
-24%
|
(29)
-18%
|
(36)
-25%
|
(38)
-6%
|
(43)
-12%
|
(51)
-19%
|
(54)
-5%
|
(65)
-20%
|
(75)
-16%
|
(74)
+2%
|
(104)
-41%
|
(253)
-143%
|
(254)
-1%
|
(256)
-1%
|
(226)
+11%
|
(69)
+69%
|
(66)
+5%
|
(45)
+32%
|
(42)
+5%
|
(40)
+6%
|
(28)
+30%
|
(34)
-21%
|
(31)
+9%
|
(33)
-6%
|
(29)
+10%
|
(28)
+5%
|
(29)
-2%
|
(28)
+2%
|
(34)
-21%
|
(40)
-18%
|
(42)
-6%
|
(38)
+9%
|
(34)
+12%
|
(27)
+21%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(20)
|
(25)
|
(22)
|
(29)
|
(31)
|
(36)
|
(51)
|
(54)
|
(65)
|
(75)
|
(74)
|
(104)
|
(252)
|
(254)
|
(256)
|
(226)
|
(69)
|
(66)
|
(44)
|
(42)
|
(40)
|
(28)
|
(34)
|
(31)
|
(33)
|
(29)
|
(28)
|
(29)
|
(28)
|
(34)
|
(40)
|
(42)
|
(38)
|
(34)
|
(27)
|
|
| Net Income (Common) |
(20)
N/A
|
(25)
-24%
|
(29)
-18%
|
(36)
-25%
|
(38)
-6%
|
(43)
-12%
|
(51)
-19%
|
(54)
-5%
|
(65)
-20%
|
(75)
-16%
|
(74)
+2%
|
(104)
-41%
|
(252)
-143%
|
(254)
-1%
|
(256)
-1%
|
(236)
+8%
|
(88)
+63%
|
(85)
+4%
|
(73)
+14%
|
(48)
+34%
|
(37)
+24%
|
(25)
+32%
|
(23)
+7%
|
(34)
-44%
|
(35)
-5%
|
(32)
+8%
|
(28)
+12%
|
(29)
-2%
|
(28)
+2%
|
(34)
-19%
|
(40)
-18%
|
(42)
-5%
|
(38)
+9%
|
(34)
+12%
|
(26)
+21%
|
|
| EPS (Diluted) |
-66.2
N/A
|
-82.1
-24%
|
-90.87
-11%
|
-151.08
-66%
|
-120.18
+20%
|
-134.81
-12%
|
-171.5
-27%
|
-119.97
+30%
|
-47.52
+60%
|
-53.52
-13%
|
-223.33
-317%
|
-176.06
+21%
|
-130.74
+26%
|
-108.96
+17%
|
-141.98
-30%
|
-86.72
+39%
|
-30.89
+64%
|
-29.39
+5%
|
-25.63
+13%
|
-15.62
+39%
|
-11.38
+27%
|
-7.71
+32%
|
-7.27
+6%
|
-10.27
-41%
|
-10.73
-4%
|
-9.82
+8%
|
-2.76
+72%
|
-0.68
+75%
|
-0.66
+3%
|
-0.78
-18%
|
-0.93
-19%
|
-0.99
-6%
|
-0.91
+8%
|
-0.79
+13%
|
-0.63
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
